Oleg Iartchouk
Novartis (Switzerland)(CH)Novartis (China)(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cell Image Analysis Techniques, Single-cell and spatial transcriptomics, Genetics, Bioinformatics, and Biomedical Research, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Genome Sequence of the Plant Pathogen and Biotechnology Agent Agrobacterium tumefaciens C58(2001)640 cited
- → Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection(2011)465 cited
- → A rare penetrant mutation in CFH confers high risk of age-related macular degeneration(2011)327 cited
- → Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a single tube assay(2005)307 cited
- → TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts(2020)194 cited
- → Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value(2016)157 cited
- → SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms(2021)72 cited
- → Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection(2009)61 cited
- → Short-term Low-Dose mTORC1 Inhibition in Aged Rats Counter-Regulates Age-Related Gene Changes and Blocks Age-Related Kidney Pathology(2018)59 cited
- → SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients(2007)44 cited